ALBIREO PHARMA INC (ALBO)
Institutional ownership reported to the SEC as of Q2 2026, across 31 quarters.
1
Reporting holders
$44
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| HUNTINGTON NATIONAL BANK | $44 | 1 | 0.00% | 19q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $44 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $44 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2025 | 1 | $44 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2025 | 1 | $744 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2025 | 1 | $744 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2025 | 1 | $744 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2024 | 1 | $744 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2024 | 1 | $744 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2024 | 1 | $744 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2024 | 1 | $744 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2023 | 1 | $744 | 1 | 0 | 0 | 0 | 0.0% |
| Q3 2023 | 1 | $744 | 1 | 0 | 0 | 0 | 0.0% |
| Q2 2023 | 1 | $756 | 1 | 0 | 0 | 0 | 0.0% |
| Q1 2023 | 3 | $2.8K | 46,081 | 0 | 0 | 2 | 0.0% |
| Q4 2022 | 81 | $360.5M | 16,618,452 | 8 | 34 | 24 | 0.5% |
| Q3 2022 | 108 | $376.0M | 19,272,797 | 22 | 41 | 27 | 1.1% |
| Q2 2022 | 100 | $355.9M | 17,754,946 | 18 | 34 | 33 | 0.9% |
| Q1 2022 | 109 | $504.3M | 16,604,421 | 19 | 29 | 39 | 1.8% |
| Q4 2021 | 95 | $422.7M | 17,991,365 | 13 | 35 | 27 | 0.9% |
| Q3 2021 | 93 | $485.2M | 15,287,305 | 4 | 38 | 30 | 1.7% |
| Q2 2021 | 97 | $636.0M | 17,882,849 | 8 | 29 | 41 | 1.1% |
| Q1 2021 | 101 | $595.9M | 16,735,119 | 6 | 37 | 36 | 1.0% |
| Q4 2020 | 105 | $636.6M | 16,707,328 | 20 | 42 | 30 | 1.6% |
| Q3 2020 | 111 | $600.5M | 16,254,807 | 43 | 36 | 25 | 9.7% |
| Q2 2020 | 80 | $277.8M | 10,264,738 | 16 | 33 | 19 | 2.1% |
| Q1 2020 | 68 | $176.1M | 10,587,385 | 11 | 37 | 12 | 1.7% |
| Q4 2019 | 69 | $232.6M | 9,144,506 | 10 | 25 | 19 | 0.1% |
| Q3 2019 | 69 | $195.9M | 9,768,574 | 8 | 33 | 12 | 0.3% |
| Q2 2019 | 74 | $298.4M | 9,259,300 | 10 | 26 | 19 | 0.0% |
| Q1 2019 | 73 | $274.9M | 8,518,119 | 7 | 26 | 20 | 0.2% |
| Q4 2018 | 67 | $197.0M | 8,134,906 | 1 | 0 | 3 | 0.0% |